Raphael J. DeHoratius

1.8k total citations
42 papers, 1.3k citations indexed

About

Raphael J. DeHoratius is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Raphael J. DeHoratius has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 10 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Raphael J. DeHoratius's work include Systemic Lupus Erythematosus Research (20 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Raphael J. DeHoratius is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Raphael J. DeHoratius collaborates with scholars based in United States, Belgium and Italy. Raphael J. DeHoratius's co-authors include Ronald P. Messner, Lawrence H. Brent, Birgit Kovacs, Alan P. Lyss, Douglas B. Cines, Kenneth S. K. Tung, J. Bruce Smith, Ralph C. Williams, R. G. Strickland and Rao J. Pillarisetty and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and JNCI Journal of the National Cancer Institute.

In The Last Decade

Raphael J. DeHoratius

41 papers receiving 1.2k citations

Peers

Raphael J. DeHoratius
L Pallarés Spain
Ariella Kelman United States
Karin Manger Germany
Ling Yin Ho China
Xavier Mariette France
P. Duffau France
Sevil Kamalı Türkiye
Karim Sacré France
Rebecca Fischer‐Betz Germany
Pascale Ghillani‐Dalbin France
L Pallarés Spain
Raphael J. DeHoratius
Citations per year, relative to Raphael J. DeHoratius Raphael J. DeHoratius (= 1×) peers L Pallarés

Countries citing papers authored by Raphael J. DeHoratius

Since Specialization
Citations

This map shows the geographic impact of Raphael J. DeHoratius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael J. DeHoratius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael J. DeHoratius more than expected).

Fields of papers citing papers by Raphael J. DeHoratius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael J. DeHoratius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael J. DeHoratius. The network helps show where Raphael J. DeHoratius may publish in the future.

Co-authorship network of co-authors of Raphael J. DeHoratius

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael J. DeHoratius. A scholar is included among the top collaborators of Raphael J. DeHoratius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael J. DeHoratius. Raphael J. DeHoratius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Stanley, Joel M. Kremer, Kimberly J. Dandreo, et al.. (2019). Outcomes of infliximab dose escalation in patients with rheumatoid arthritis. Clinical Rheumatology. 38(9). 2501–2508. 1 indexed citations
2.
Tesser, John, Shelly Kafka, Raphael J. DeHoratius, et al.. (2019). Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age. Arthritis Research & Therapy. 21(1). 190–190. 7 indexed citations
3.
DeHoratius, Raphael J., et al.. (2018). Patient Perspectives on Intravenous Biologics for Rheumatologic Disease. Arthritis Care & Research. 71(9). 1234–1242. 7 indexed citations
4.
Baraf, Herbert S. B., et al.. (2018). The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients. Drugs in R&D. 18(3). 211–219. 4 indexed citations
5.
DeHoratius, Raphael J., Lawrence H. Brent, Jeffrey R. Curtis, Lorie Ellis, & Kezhen L. Tang. (2018). Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept. Patient. 11(3). 361–369. 12 indexed citations
6.
Gaylis, Norman, et al.. (2017). Patient-reported outcome assessment of inflammatory arthritis patient experience with intravenously administered biologic therapy. Patient Preference and Adherence. Volume 11. 1543–1553. 3 indexed citations
7.
DeHoratius, Raphael J., et al.. (2007). Calciphylaxis: An important imitator of cutaneous vasculitis. Arthritis Care & Research. 57(3). 533–537. 9 indexed citations
8.
Derk, Chris T. & Raphael J. DeHoratius. (2004). Systemic lupus erythematosus and acute pancreatitis: a case series. Clinical Rheumatology. 23(2). 147–151. 46 indexed citations
9.
DeHoratius, Raphael J., et al.. (2004). Musculoskeletal manifestations of endocrine disorders. Current Opinion in Rheumatology. 17(1). 64–69. 21 indexed citations
10.
DeHoratius, Raphael J.. (2004). Ex nihilo nihil fit. Arthritis & Rheumatism. 50(2). 350–352. 3 indexed citations
11.
McGrory, Carolyn H., et al.. (2003). Pregnancy Outcomes in Female Renal Recipients: A Comparison of Systemic Lupus Erythematosus With Other Diagnoses. American Journal of Transplantation. 3(1). 35–42. 18 indexed citations
12.
McGrory, Carolyn H., et al.. (2000). PREGNANCY OUTCOMES IN FEMALE RENAL RECIPIENTS: A COMPARISON OF SYSTEMIC LUPUS ERYTHEMATOSUS TO OTHER DIAGNOSES.. Transplantation. 69(Supplement). S289–S289. 1 indexed citations
13.
Kovacs, Birgit, et al.. (2000). Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Annals of the Rheumatic Diseases. 59(2). 120–124. 229 indexed citations
14.
Smith, J. Bruce, et al.. (1997). Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus. Arthritis & Rheumatism. 40(4). 775–778. 41 indexed citations
15.
Goldenberg, Don L., Raphael J. DeHoratius, Stephen R. Kaplan, et al.. (1985). Rheumatology training at internal medicine and family practice residency programs. Arthritis & Rheumatism. 28(4). 471–476. 18 indexed citations
16.
Edeiken, Jack, et al.. (1985). Medically reversible quadriparesis in tophaceous gout.. PubMed. 66(3). 188–90. 29 indexed citations
17.
Clair, David St, Raphael J. DeHoratius, John H. Wolfe, & R.E.W. Halliwell. (1980). Autoantibodies in human contacts of sle dogs. Arthritis & Rheumatism. 23(2). 251–253. 6 indexed citations
18.
DeHoratius, Raphael J., Rao J. Pillarisetty, Ronald P. Messner, & Norman Talal. (1975). Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.. Journal of Clinical Investigation. 56(5). 1149–1154. 59 indexed citations
19.
DeHoratius, Raphael J., et al.. (1974). T and B lymphocytes in acute and chronic hepatitis. Clinical Immunology and Immunopathology. 2(3). 353–360. 79 indexed citations
20.
DeHoratius, Raphael J.. (1972). Immunofluorescent and Immunologic Studies of Rheumatoid Lung. Archives of Internal Medicine. 129(3). 441–441. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L Pallarés Breakdown of academic impact, for papers by Ariella Kelman Breakdown of academic impact, for papers by Karin Manger Breakdown of academic impact, for papers by Ling Yin Ho Breakdown of academic impact, for papers by Xavier Mariette Breakdown of academic impact, for papers by P. Duffau Breakdown of academic impact, for papers by Sevil Kamalı Breakdown of academic impact, for papers by Karim Sacré Breakdown of academic impact, for papers by Rebecca Fischer‐Betz Breakdown of academic impact, for papers by Pascale Ghillani‐Dalbin
Rankless by CCL
2026